Dr. Philip M. Arlen, CEO, to give opening keynote for Immunotherapy Section of Festival of Biologics, San Diego, CA, April 15, 2024
DOWNLOAD PRESENTATION
DOWNLOAD PRESENTATION
Precision Biologics will present recent scientific data at the American Association for Cancer Research (AACR)...
Dr. Philip M. Arlen, President & CEO of Precision Biologics, Inc. will deliver a scientific...
Natural killer (NK) cells are cellular components of the innate immune system that can recognize...
Precision Biologics presents new data from ongoing NEO-201 clinical trial at the Society for Immunotherapy...
Precision Biologics Announces the United States Patent and Trademark Office (USPTO) has granted a Patent...
Precision Biologics announces that Massimo Fantini PhD, our Director of Research and Development, will deliver...
A poster will be presented in person at the American Association for Cancer Research (AACR)...
Precision Biologics, Inc. publishes data and analysis from recent First-In-Human Phase 1 Clinical Trial With...
Dr. Philip M. Arlen, President and CEO, Precision Biologics, gives keynote address entitled “Preclinical/Clinical Development...